Does Appbutamone Combination Package Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SYMPATHOMIMETICS (INDIRECT & MIXED ACTING)/MAOIS
- BUPROPION; SOLRIAMFETOL/MAO INHIBITORS
- CYP1A2 INHIBITORS/FEZOLINETANT
- BUPROPION/PIMOZIDE; THIORIDAZINE
- ANTIDEPRESSANTS/SIBUTRAMINE
- SELECTED ANTIDEPRESSANTS/IOMEPROL
- XANTHINE DERIVATIVES/DIPYRIDAMOLE INJECTABLE
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- THEOPHYLLINE DERIVATIVES/CIMETIDINE
- ASPARTAME; PHENYLALANINE; TYROSINE/NITISINONE
- MIXED;INDIRECT SYMPATHOMIMETICS/SELECTED MAOIS
- SELECTED CYP1A2 SUBSTRATES/VILOXAZINE
- BUPROPION; SOLRIAMFETOL/LINEZOLID
- BUPROPION/STRONG CYP2B6 INDUCERS
- MIXED;INDIRECT SYMPATHOMIMETICS/RASAGILINE
- SELECTED MODERATE AND WEAK CYP1A2 INHIBITORS/TIZANIDINE
- BUPROPION/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- AGENTS THAT AFFECT CATECHOLAMINES/IOBENGUANE I 123
- AGENTS THAT AFFECT CATECHOLAMINES/IOBENGUANE I 131
- SELECTED STRONG CYP2D6 INHIBITORS/METOCLOPRAMIDE
- STRONG & MODERATE CYP2D6 INHIBITORS/ELIGLUSTAT
- DOPAMINE TRANSPORTER BINDERS/IOFLUPANE I 123
- SELECTED STRONG CYP2D6 INHIBITORS/TAMOXIFEN
- XANTHINE DERIVATIVES/ADENOSINE; HEXOBENDINE; REGADENOSON
- STRONG 2D6 INHIBITORS/ATOMOXETINE; VORTIOXETINE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- THEOPHYLLINE DERIVATIVES/LITHIUM
- SELECTED XANTHINE DERIVATIVES/FLUVOXAMINE
- BUPROPION/ANTIPSYCHOTICS
- BUPROPION/SELECTED ANTIDEPRESSANTS
- BUPROPION/THEOPHYLLINE
- BUPROPION/STEROIDS
- BUPROPION/HYPOGLYCEMICS; INSULIN
- BUPROPION/MODERATE CYP2B6 INDUCERS
- BUPROPION/TRICYCLIC ANTIDEPRESSANTS
- BUPROPION/SNRIS; SSRIS
- SELECTED SENSITIVE CYP2B6 SUBSTRATES/MIDOSTAURIN
- SELECTED SENSITIVE CYP2B6 SUBSTRATES/LEMBOREXANT
- CAFFEINE-CONTAINING PRODUCTS/MIGALASTAT
- BUPROPION/SELECTED LONG-ACTING ARIPIPRAZOLE
- SELECTED STRONG CYP2D6 INHIBITORS/DEXTROMETHORPHAN
- STRONG CYP1A2 OR CYP2D6 INHIBITORS/FENFLURAMINE
- STRONG CYP2D6 INHIBITORS/MEXILETINE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP2D6 INHIBITORS/PITOLISANT
- BUPROPION/ILOPERIDONE; ZUCLOPENTHIXOL
- BUPROPION/ARIPIPRAZOLE
- BUPROPION/AMANTADINE; FOSLEVODOPA; LEVODOPA
- SELECTED CYP2D6 INHIBITORS/METOPROLOL
- STRONG CYP2D6 INHIBITORS/OXYCODONE
- STRONG 2D6 INHIBITORS/VALBENAZINE
- SELECTED STRONG CYP2D6 INHIBITORS/FLECAINIDE
- SELECTED MODERATE TO STRONG CYP2D6 INHIBITORS/TRAMADOL
- STRONG CYP2D6 INHIBITORS/DEUTETRABENAZINE;TETRABENAZINE
- SELECTED CYP2D6 INHIBITORS/PERHEXILINE
- STRONG CYP2D6 INHIBITORS/CODEINE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.